Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

35.77
+2.527.58%
Post-market: 35.54-0.2300-0.64%17:01 EDT
Volume:264.92K
Turnover:9.11M
Market Cap:145.05M
PE:- -
High:35.77
Open:32.84
Low:32.73
Close:33.25
52wk High:42.39
52wk Low:13.60
Shares:4.05M
Float Shares:4.05M
Volume Ratio:0.98
T/O Rate:6.53%
Dividend:15.23
Dividend Rate:42.59%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

24H | Semtech Jumps 4%; Zoom Falls 4%; Intuit Tumbles 10% After Earnings Results

US Overnight
·
Aug 26

Moderna (MRNA) Is Up 151.8% After First Positive Phase 3 mRNA Cancer Therapy Result - What's Changed

Simply Wall St.
·
Aug 26

Trading DAY-Oil, Yields Slide

Reuters
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Aug 26

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Top Calls On Wall Street: Nvidia, AMD, SpaceX, Netflix, Dell, Coinbase, Moderna, Strategy, and More

Tiger Newspress
·
Aug 25

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

Market Movers | Bloom Energy Rises on Pelosi Buy; Nebius, NetEase Gain on Goldman Calls; Moderna Rallies

Tiger Newspress
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25